| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 6 | |
| #2 | Canada | 2 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | Republic of Korea | 2 | |
| #5 | Mexico | 2 | |
| #6 | Argentina | 1 | |
| #7 | Australia | 1 | |
| #8 | Brazil | 1 | |
| #9 | Hong Kong | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Name | Total Patents |
|---|---|---|
| #1 | Alonso Robert | 14 |
| #2 | Geisler John Gerard | 14 |
| #3 | Albayati Zaineb | 5 |
| #4 | Crooks Peter Anthony | 5 |
| #5 | Penthala Narsimha Reddy | 5 |
| #6 | John Gerard Geisler | 3 |
| #7 | Robert Alonso | 3 |
| #8 | Zaineb Albayati | 1 |
| #9 | Narsimha Reddy Penthala | 1 |
| #10 | Peter Anthony Crooks | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2017252347A1 | DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases | |
| BR112017015721A2 | induced expression of brain derived neurotrophic factor (bdnf) for the treatment of neuromuscular, neurodegenerative, autoimmune, developmental and / or metabolic disorders. |